Allergan Lap-Band gets added panel backing: report

SAN FRANCISCO (MarketWatch) -- Shares of Allergan Inc.
AGN, +2.01%
rose in after-hours activity Friday after the medical products company reportedly got a nod from a Food and Drug Administration advisory panel for a wider use of their weight-loss surgery device. Allergan shares rose 3.3% to $71.05 on light volume in after-hours activity. The FDA's Gastroenterology and Urology Devices advisory panel voted 8 to 2 recommending that the FDA approve use of Allergan's Lap-Band device to treat less-severe obesity, according to media reports. The FDA is not bound to follow their advisory panels' recommendations but often does. The expanded labeling on the device could make it available to 27 million more Americans, according to reports.

Intraday Data provided by SIX Financial Information and subject to terms of use.
Historical and current end-of-day data provided by SIX Financial Information. Intraday data
delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Dow Jones & Company, Inc.
All quotes are in local exchange time. Real time last sale data provided by NASDAQ. More
information on NASDAQ traded symbols and their current financial status. Intraday
data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. S&P/Dow Jones Indices (SM)
from Dow Jones & Company, Inc. SEHK intraday data is provided by SIX Financial Information and is
at least 60-minutes delayed. All quotes are in local exchange time.